Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Refractory Anemia With Excess Blasts Clinical Trials References presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, trips or professional assistance using a genuine dr.. We aren't physicians. Always consult your mD about Refractory Anemia With Excess Blasts conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Refractory Anemia With Excess Blasts Clinical research trials and Refractory Anemia With Excess Blasts health trials take place in a lot of of cities across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new does drugs. The propose of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to discover remedies for all kinds of circumstances, including Refractory Anemia With Excess Blasts. Refractory Anemia With Excess Blasts Clinical Trials and other clinical trials permit volunteers to have medical treatment options before they are available to the masses. Most times the test subjects obtain treatment for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Refractory Anemia With Excess Blasts clinical trial. Subjects often recieve the best healthcare available for their Refractory Anemia With Excess Blasts problem. Dangers are a reality, nonetheless, and can include additional or frequent physician trips, medical risks (possibly life-threatening), and/or the treatment being ineffectual. Trials are federally governed with rigid guidelines to protect clinical trials patients.

Home > Clinical Trials by Conditions > "R" Clinical Trial Conditions > Refractory Anemia With Excess Blasts Clinical Trials

Refractory Anemia With Excess Blasts Clinical Trials



Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
Condition: swiss_institute_for_applied_cancer_research_clinical_trials.html
Swiss Institute for Applied Cancer Research

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
Condition: sangstat_medical_corporation_clinical_trials.html
Sangstat Medical Corporation

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
Condition: university_of_maryland_greenebaum_cancer_center_clinical_trials.html
University of Maryland Greenebaum Cancer Center

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
Condition: medical_college_of_pennsylvania_hospital_clinical_trials.html
Medical College of Pennsylvania Hospital

Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
Condition: alza_clinical_trials.html
ALZA

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
Condition: medical_research_council_clinical_trials.html
Medical Research Council

Daclizumab Compared With Antithymocyte Globulin in Treating Cytopenia in Patients With Myelodysplastic Syndromes
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)

Decitabine Compared With Supportive Care in Treating Patients With Advanced Myelodysplastic Syndromes
Condition: supergen_clinical_trials.html
SuperGen

Decitabine in Treating Patients With Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
Condition: eortc_leukemia_cooperative_group_clinical_trials.html
EORTC Leukemia Cooperative Group

Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group

Infliximab in Treating Patients With Myelodysplastic Syndrome
Condition: eortc_leukemia_cooperative_group_clinical_trials.html
EORTC Leukemia Cooperative Group

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
Condition: eortc_biological_therapeutics_development_study_group_clinical_trials.html
EORTC Biological Therapeutics Development Study Group

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Thalidomide in Treating Patients With Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)



Refractory Anemia With Excess Blasts Clinical Trials

Modify your Search

Refractory Anemia With Excess Blasts Clinical Trials by State:

Alabama
Arizona
Arkansas
California
Colorado
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
South Carolina
South Dakota
Tennessee
Texas
Utah
Washington
Wisconsin

Other "R" Clinical Trials Conditions:

Radiation Enteritis
Radiation Fibrosis
Radiation Injuries
Radiation Toxicity
Radiculitis
Radiculopathy
Raman Spectroscopy
Rapid Cycling Bipolar Disorder
Raynaud Disease
Raynaud's Disease
Rectal Cancer
Rectal Neoplasms
Recurrence
Recurrent Abdominal Pain
Recurrent Adenoid Cystic Carcinoma Of The Oral Cavity
Recurrent Adrenocortical Carcinoma
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Adult Acute Lymphocytic Leukemia
Recurrent Adult Acute Myeloid Leukemia
Recurrent Adult Brain Tumor
Recurrent Adult Burkitt's Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Adult Diffuse Mixed Cell Lymphoma
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
Recurrent Adult Diffuse Small Noncleaved Cell/burkitt's Lymphoma
Recurrent Adult Hodgkin's Disease
Recurrent Adult Hodgkin's Lymphoma
Recurrent Adult Immunoblastic Large Cell Lymphoma
Recurrent Adult Lymphoblastic Lymphoma
Recurrent Adult Non-Hodgkin's Lymphoma
Recurrent Adult Primary Liver Cancer
Recurrent Adult Soft Tissue Sarcoma
Recurrent Adult T-Cell Leukemia/lymphoma
Recurrent Angiocentric Immunoproliferative Lesions
Recurrent Bladder Cancer
Recurrent Brain Tumor
Recurrent Breast Cancer
Recurrent Carcinoma Of Unknown Primary
Recurrent Cervical Cancer
Recurrent Childhood Acute Lymphoblastic Leukemia
Recurrent Childhood Acute Myeloid Leukemia
Recurrent Childhood Brain Stem Glioma
Recurrent Childhood Brain Tumor
Recurrent Childhood Cerebellar Astrocytoma
Recurrent Childhood Cerebral Astrocytoma
Recurrent Childhood Ependymoma
Recurrent Childhood Hodgkin's Disease
Recurrent Childhood Large Cell Lymphoma
Recurrent Childhood Liver Cancer
Recurrent Childhood Lymphoblastic Lymphoma
Recurrent Childhood Malignant Germ Cell Tumor
Recurrent Childhood Medulloblastoma
Recurrent Childhood Rhabdomyosarcoma
Recurrent Childhood Small Noncleaved Cell Lymphoma
Recurrent Childhood Soft Tissue Sarcoma
Recurrent Childhood Supratentorial Primitive Neuroectodermal And Pineal Tumors
Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumors
Recurrent Childhood Visual Pathway Glioma
Recurrent Colon Cancer
Recurrent Cutaneous T-Cell Lymphoma
Recurrent Diffuse Small Lymphocytic/marginal Zone Lymphoma
Recurrent Endometrial Cancer
Recurrent Esophageal Cancer
Recurrent Extrahepatic Bile Duct Cancer
Recurrent Gallbladder Cancer
Recurrent Gastric Cancer
Recurrent Gastrointestinal Carcinoid Tumor
Recurrent Gestational Trophoblastic Tumor
Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Recurrent Grade I Follicular Small Cleaved Cell Lymphoma
Recurrent Grade Ii Follicular Mixed Cell Lymphoma
Recurrent Grade Iii Follicular Large Cell Lymphoma
Recurrent Intraocular Melanoma
Recurrent Kaposi's Sarcoma
Recurrent Malignant Mesothelioma
Recurrent Malignant Thymoma
Recurrent Mantle Cell Lymphoma
Recurrent Melanoma
Recurrent Merkel Cell Carcinoma
Recurrent Metastatic Squamous Neck Cancer With Occult Primary
Recurrent Mycosis Fungoides/sezary Syndrome
Recurrent Neuroblastoma
Recurrent Non-Small Cell Lung Cancer
Recurrent Osteosarcoma
Recurrent Ovarian Epithelial Cancer
Recurrent Ovarian Germ Cell Tumor
Recurrent Pancreatic Cancer
Recurrent Peripheral Primitive Neuroectodermal Tumor
Recurrent Prostate Cancer
Recurrent Rectal Cancer
Recurrent Renal Cell Cancer
Recurrent Respiratory Papillomatosis
Recurrent Retinoblastoma
Recurrent Salivary Gland Cancer
Recurrent Skin Cancer
Recurrent Small Cell Lung Cancer
Recurrent Small Intestine Cancer
Recurrent Small Lymphocytic Lymphoma
Recurrent Squamous Cell Carcinoma Of The Hypopharynx
Recurrent Squamous Cell Carcinoma Of The Larynx
Recurrent Squamous Cell Carcinoma Of The Lip And Oral Cavity
Recurrent Squamous Cell Carcinoma Of The Nasopharynx
Recurrent Squamous Cell Carcinoma Of The Oropharynx
Recurrent Squamous Cell Carcinoma Of The Paranasal Sinus And Nasal Cavity
Recurrent Testicular Cancer
Recurrent Thymoma And Thymic Carcinoma
Recurrent Thyroid Cancer
Recurrent Transitional Cell Cancer Of The Renal Pelvis And Ureter
Recurrent Tumors Of The Ewing's Family
Recurrent Urethral Cancer
Recurrent Uterine Sarcoma
Recurrent Vulvar Cancer
Recurrent Wilms' Tumor And Other Childhood Kidney Tumors
Recurrent/refractory Childhood Hodgkin's Disease
Recurrent/refractory Childhood Hodgkin's Lymphoma
Red-Cell Aplasia, Pure
Reduction Of Total Body Iron Storage(tbis)
Reflex Sympathetic Dystrophy
Refractive Error
Refractory Anemia
Refractory Anemia With Excess Blasts
Refractory Anemia With Excess Blasts In Transformation
Refractory Anemia With Ringed Sideroblasts
Refractory Chronic Lymphocytic Leukemia
Refractory Chronic Myelogenous Leukemia
Refractory Cytopenia
Refractory Hairy Cell Leukemia
Refractory Lymphoma
Refractory Plasma Cell Neoplasm
Regional Gastrointestinal Carcinoid Tumor
Regional Neuroblastoma
Regional Transitional Cell Cancer Of The Renal Pelvis And Ureter
Rehabilitation
Reiter's Disease
Relapsed Lymphoma
Relapsing Chronic Myelogenous Leukemia
Relapsing-Remitting Multiple Sclerosis
Renal Allograft Recipients
Renal Anemia
Renal Artery Obstruction
Renal Cancer
Renal Cell Adenocarcinoma
Renal Cell Cancer
Renal Cell Carcinoma
Renal Clear Cell Carcinoma
Renal Failure
Renal Granular Cell Carcinoma
Renal Insufficiency, Chronic
Renal Neoplasm
Renal Osteodystrophy
Renal Transplant Recipients
Renovascular Hypertension
Reproductive Cancer
Reproductive Cancers
Respiration Disorders
Respiratory Acidosis
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Adult
Respiratory Insufficiency
Respiratory Papillomas
Respiratory Syncytial Virus Infection
Respiratory Syncytial Virus Infections
Respiratory Tract Diseases
Rest Leg Pain
Restless Legs Syndrome
Retinal Degeneration
Retinal Detachment
Retinal Disease
Retinal Diseases
Retinal Hemangioblastoma
Retinal Neovascularization
Retinal Vasculitis
Retinal Vein Occlusion
Retinitis
Retinitis Pigmentosa
Retinoblastoma
Retinopathy Of Prematurity
Retinoschisis
Retroviridae Infections
Rett Syndrome
Rhabdoid Tumor Of The Kidney
Rhabdomyosarcoma
Rheumatic Disease
Rheumatic Diseases
Rheumatoid Arthritis
Rhinitis
Rhinitis, Allergic, Nonseasonal
Rhinitis, Allergic, Seasonal
Rickets


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103